Упрощенная HTML-версия
154
176. Bigger J. T. Frequency domain measures of heart period variability and
mortality after myocardial infarction / J.T. Bigger, J.L. Fleiss, R.C. Steinman //
Circulation. – 1992. – Vol. 85. – P. 164-171.
177. Casolo G.C. Heart rate variability during the acute phase of myocardial
infarction / G. C. Casolo, P. Stroder, C. Signorini // Circulation. – 1992. – Vol. 85. –
P. 2073-2079.
178. Cerati D. Influence of residual ischemia of heart rate variability after
myocardial infarction / D. Cerati, F. Nador, R. Maestry // Eur Heart J. – 1997. – Vol.
18. – P. 78-83.
179. Cerra F. Hypermetabolism – organ failure syndrome: metabolic response
to injury / F. Cerra // Surgery. – 1991. – V. 185. - P. 47-55.
180. Clinical significance of variability of ventricular late potentials detected
before discharge in patients after myocardial infarction // Am. Heart J. – 2000. – Vol.
139. – P. 134-141.
181. Coker R. Lessons from New York’s tuberculosis epidemic / R. Coker //
The Brit. Med. J. – 1998. – Vol. 317, P. 616-620.
182. Comporti M. Lipid peroxydation and biogenic aldehydes: from the
identification of 4-hydroxynonenal to further achievements in biopathology / M.
Comporti // Free radic. Res. - 1998. – V. 28. – Р. 623-635.
183. Cripps T. K. Prognostic value of reduced of heart rate variability after
myocardial infarction: clinical evolution of anew analysis methods / T.K. Cripps, M.
Malik, T.O. Farell // Br. Heart. J. – 1991. – Vol. 65. – P. 14-19.
184. Сytokine regulation of monocyte recruitment / A. Mantovani [et al.] //
Arch. Immunol. Ther. Exp. (Warsz). – 1995. – Vol.43, № 2. – P. 149-152.
185. Сytokine regulation of endothelial cell function: from molecular level to
the bedside / A. Mantovani [et al.] // Immunol. Today. – 1997. - Vol. 17, № 2. – P.
254-261.